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BIRTH WEIGHT AS A RISK FACTOR FOR AUTISM SPECTRUM DISORDERS: A
PILOT STUDY AND CASE-CONTROL STUDY.
Virginia Grace Cohen; Myriam Peralta-Carcelen and Crayton Fargason (Department of
Pediatrics, University of Alabama School of Medicine); Fred Volkmar (Child Study
Center, Yale University School of Medicine)

The role of birth weight and perinatal adversity in the development of autism
spectrum disorders (ASDs) remains controversial. Our objective was to clarify the
relationship between ASDs and low birth weight, with particular focus on the effects of
extremely low birth weight (ELBW). In part one of this study, we tested a cohort of
ELBW children ages 3-7 for ASDs using the Autism Diagnostic Observation Schedule
(ADOS) as our primary assessment tool, and the Autism Behavior Checklist, Autism
Screening Questionnaire, and the Vineland Adaptive Behavior Scales as secondary tests.
Of 19 ELBW participants, 3 had ADOS total scores in the ASD or autism range; one of
the three scored in the ASD range on all tests administered. In addition, 7 had abnormal
scores on the ADOS communication domain, and 4 on the social interaction domain. In
part two, we conducted a case-control study to look at birth weight and perinatal
adversity in children with autism or pervasive developmental disorder vs. controls. In
this portion of the study (n=296), mean birth weight was not significantly different
among the autism, PDD, and control groups (p=0.523). In those with IQ<70, there was a
noticeable but nonsignificant trend toward higher birth weight in the autism group
(p=0.132). There were no differences in specific adverse perinatal factors among groups.
While our data suggest that low birth weight and perinatal adversity are not major risk
factors for ASDs, more research is necessary to determine whether the small subgroup of
ELBW children may have a tendency to develop autism-like behavioral derangements.
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Introduction

Since autism was first described by Leo Kanner in 1943, the etiology of this
mysterious disorder has fascinated both the medical community and the general public.
Interest has been sparked in recent years by what appears to be a significant increase in
the prevalence of autism spectrum disorders, a puzzling phenomenon that has not yet
been fully explained. As the number of American children with autism and related
conditions has grown, so has recognition of the critical importance of research into this
field; in the fall of 2003, the federal government launched a long-term initiative aimed at
promoting biomedical research, establishing better screening and diagnostic tools, and
formulating more effective therapies for autistic disorders (1). In this climate, defining
and understanding the risk factors for autism is a necessary step in early diagnosis and,
ultimately, prevention of the disorder.
Autism is characterized by qualitative deficits in communication and reciprocal
social interaction, and by repetitive or stereotyped behaviors and interests (see Appendix
A for full diagnostic criteria [2]). Onset occurs in early childhood, usually before age
three. Autism is frequently marked by language delay and impoverished imagination,
and is more likely to affect boys than girls (3). Intellectual function is impaired in
approximately 75% of children with autism; one recent meta-analysis (4) demonstrated
that 23.5% of autistic subjects were without intellectual impairment, 22.3% had mild to
moderate impairment (IQ 35-70), and 54.9% had a severe to profound level of mental
retardation (IQ <35). Autism spectrum disorder (ASD), synonymous with pervasive
developmental disorder (PDD), is an umbrella term that encompasses a variety of related
disorders — such as Asperger syndrome, PDD not otherwise specified (PDD-NOS)),
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atypical autism, and autism itself — that span a continuum of social and communication
deficits.
The incidence and prevalence of ASDs are somewhat controversial, with
prevalence estimates increasing dramatically over the last decade. Recent meta-analyses
(5,6) of epidemiological studies conservatively estimate the prevalence of autism to be
about 10 per 10,000 (up from estimates of 2-5 per 10,000 in the 1970s) and the
prevalence of ASDs to fall between 20 and 50 per 10,000. One of the more recent
prevalence studies (7), published in June of 2001, found a rate of 16.8 per 10,000 for
autistic disorder and 62.6 per 10,000 for ASDs, inclusive of autism. Other research (810) has yielded even higher numbers: 21-40 per 10,000 for autism and 58-67 per 10,000
for all ASDs combined. At present, it is not known whether these growing numbers
reflect changing diagnostic definitions of autism and ASDs, heightened awareness among
healthcare professionals and the public, a true rise in incidence, or some combination of
these factors. Data from the Minnesota public school system (11) suggests that while
autism rates have been rising, there have been no decreases in other categories of
educational disability to suggest diagnostic substitution as the sole explanation for the
increasing ASD rates. Regardless of the reason for the rise, however, disorders of this
type have become a significant and fairly common pediatric concern.
Autism spectrum disorders are generally thought to result from a complex
interplay between genetics and neurobiological factors, likely occurring when
environmental influences act on a genetically susceptible individual (12,13). The precise
etiology is unknown in most cases, but an underlying disorder or aberration can be
pinpointed in a minority of individuals with an ASD (14). Twin and family studies, as
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well as molecular and cytogenetic research, have established a strong genetic component
to autism (15-17). Concordance rates are much higher for monozygotic twins (80-90%)
then for dizygotic (9-30% [18-20]). The reported rate of autism among siblings ranges
from 2-7%, with siblings of autistic patients 50-200 times more likely to have autism than
members of the general population (21-22, 13). The genetics of autism are certainly
complex, likely involving multiple genes that have yet to be identified.
Associations have been demonstrated between autism and tuberous sclerosis,
neurofibromatosis, fragile X syndrome, and seizure disorders (23-26).

Congenital

infections, lead poisoning, metabolic diseases, brain lesions, and neurochemical
abnormalities may also be associated with autism, although the evidence for these is
relatively weak (27). (Of note, several recent studies [28,29] have failed to find any
association between the measles, mumps, and rubella [MMR] vaccine and the
development of autism.) Overall, the rate of concurrence between autism and known
medical conditions is estimated to be about 10-25% (30,31).
Courchesne and colleagues (32) have recently demonstrated that reduced head
size at birth, followed at 6-14 months of age by an abnormally accelerated pattern of
brain and head growth, is associated with autism spectrum disorders. The authors of this
paper, who noted the unusual growth trajectory in 59% of children with an ASD
compared to 6% of normal children, have speculated that abnormal brain expansion
creates “noise” that may limit a child’s ability to learn about and interact with the outside
world, and a critical window of time in development may be irretrievably lost. Other
neurologic studies (33,34) have revealed patterns of limbic and cerebellar abnormalities
in the brains of some autistic patients.
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Because most cases of autism are idiopathic, further investigation into the causes
and risk factors of the disorder is essential. Some researchers, mindful of the link
between neurologic insults and autism, have hypothesized that obstetrical complications
may be a risk factor for the disorder. In 1980, Deykin and MacMahon (35) found that
autistic children were more likely than their nonautistic siblings to have experienced at
least one adverse event in the pre-, peri-, or neonatal phase. The authors concluded that
general physical damage resulting from unfavorable events might lead to the
development of autism, but that no single complication could be named responsible.
Several later studies (36-38) have provided further support for the notion that nonspecific
pre-, peri-, or neonatal factors may contribute to autism, although a consistent pattern of
risk factors has not been demonstrated. A wide variety of conditions and complications
including maternal medication use, maternal smoking, increased paternal age, intrauterine
stress, abnormal presentation at delivery, decreased birth weight, and hyperbilirubinemia
have been implicated in the last few years with the later development of an ASD (39-42).
Other studies, however, have called these findings into question. Piven, et al. (43)
found that adjusting for birth order eliminated apparent differences in obstetrical
optimality between autistic children and their siblings.

Another study of 49 autistic

children (44) found no difference in maternal age, maternal parity, birth order, or low
birth weight between the autistic children and controls. Two additional groups have failed
to find a relationship either between specific pathologic factors or groups of factors and
autism (45) or between general suboptimality and autism (46).
Taken as a whole, research into the relationship between autism and obstetric or
perinatal adversity is inconclusive and merits further study. Even those studies that have
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found a link between adverse conditions and autism disagree as to precisely which
conditions are to blame, and it is difficult to find among the potential risk factors any
unifying features that would suggest pathogenesis. Most existing studies document the
risk of developing autism, but do not address disorders within the broader autism
spectrum such as PDD-NOS. Furthermore, no one has yet considered the effects of
extremely low birth weight, as opposed to low birth weight in general, on the
development of autistic behaviors.
As medical advances such as surfactant and maternal steroid use have improved
survival for infants of low birth weight and gestational age, a new cohort of extremely
low birth weight (ELBW) children has arisen. Traditionally, low birth weight children
have been stratified into three categories: low birth weight (<2500g), very low birth
weight (<1500g), and extremely low birth weight (<1000g). In 2000, according to a
report by the Center for Disease Control and Prevention, 7.6% of infants bom were low
birth weight (LBW), and 1.5% were very low birth weight (VLBW). A much smaller
proportion were ELBW (0.7% according to 1997 data [47]). Survival correlates with
birth weight and gestational age, ranging from 11.6% for birth weights <500g to 83.9%
for birth weights of 750-1000g to 98.4% for birth weights of 1500-2500g (48).
ELBW children, who are typically bom at or before 27 weeks’ gestational age,
are at greater risk than their higher birth weight counterparts for the various
complications of premature birth, including chronic lung disease, severe brain injury,
necrotizing enterocolitis, nosocomial infections, and retinopathy of prematurity (ROP).
Rates of severe disability, such as mental retardation, cerebral palsy, blindness, and/or
deafness, are also high in this population (49).

(Notably, although the mortality rate for
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ELBW infants has declined, the proportion of those with severe sequelae has not).
Overall, about 20% of ELBW are significantly disabled (50); this proportion rises to 50%
among infants bom between 500-750g (51).
As they age, ELBW children attain lower growth measurements than their peers
(52) and are more likely to develop deficits in executive function (affecting planning,
sequencing, and inhibition) and limitations in cognition, sensation, mobility, and self-care
(53-55). They experience significantly more neurologic problems than controls, as well
as reduced visual-motor function, visual-perceptual abilities, and attention span (56).
Extremely low birth weight has been linked to impaired cognitive and motor
development in preschool-age children (57) and the need for special education services in
school-age children (50). Furthermore, school-age ELBW children as a group score
significantly lower than controls on IQ tests, school achievement tests, and motor
performance (58). These difficulties follow surviving ELBW children into adolescence,
where they continue to have a higher prevalence of visual problems, seizures,
developmental delay, learning disabilities, hyperactivity, and use of community resources
than controls, although some catch-up growth and improvement in health does tend to
occur (59).
Interestingly, although no one has directly investigated the link between ELBW
and autism, a strong association has been found between autism and blindness due to
retinopathy of prematurity (ROP), a disease for which risk increases as birth weight
decreases. In this study (60), undertaken by a group in Sweden, 15 of 27 children in the
ROP group (with gestational ages between 25-30 weeks) had autistic disorder, and an
additional 4 had autistic-like conditions. The authors speculated that both blindness from
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ROP and autism were mediated by brain damage in these children.

Only 2 of 14 controls

(children with congenital blindness secondary to hereditary retinal disease) were found to
be autistic.
Although no cure for autism exists, outcome can be markedly improved by early
diagnosis and intervention (61-63). Current intervention strategies recommended by the
American Academy of Child and Adolescent Psychiatry and the American Academy of
Pediatrics include behavior management, structured play therapy, early developmental
education or school-based special education, and speech, occupational, and physical
therapy (64, 65). The National Research Council issued a detailed report in 2001 (66)
with an analysis of available interventions and recommendations for schools, parents, and
the community on educating children with autism. Pharmacologic treatment is also
available both for autism-related behaviors and for concurrent psychiatric conditions (6771). In recent years, encouraged by the development of better treatment options and
diagnostic instruments and by growing concerns over the prevalence of autism, health
professionals have placed increasing emphasis on the importance of early screening and
diagnosis of autism and ASDs (72-73, 64).
In this context, it is vitally important that potential risk factors for autism be
defined and investigated. In part one of this study, a sample population of ELBW infants
was tested for autistic behaviors using three instruments, the Autism Diagnostic
Observation Schedule (ADOS [74]), Autism Behavior Checklist (ABC [75]), and Autism
Screening Questionnaire (ASQ [76]). Results of the ADOS, an assessment designed to
differentiate among autism proper, ASDs, and nonspectrum diagnoses based on the
number and severity of observed behaviors, were used as the primary outcome measure.
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In addition, the Vineland Adaptive Behavior Scales (77) were administered to assess
level of development in communication, socialization, and daily living skills.
Given that extreme prematurity is known to put children at risk for a host of
developmental and behavioral sequelae, and that the incidence of ELBW survivors and
prevalence of ASDs have both risen within a similar time frame, we hypothesized that
this group of children was more likely than the average population to display autismrelated social and communication deficits and behavioral abnormalities. The primary
goal of this pilot study was to determine if a more extensive investigation into the link
between extreme prematurity and autistic behavior is warranted. Because early diagnosis
and treatment are very important in determining future outcome, this study was designed
to help clarify whether ELB W is a risk factor for ASDs and whether routine screening for
autism is called for in this population of children.
The second part of this study approached the question of low birth weight as a
risk factor for ASDs from a retrospective angle. A case-control study was performed
using the medical records of children seen in a Developmental Disabilities Clinic. This
study compared the birth weights of children with autism or PDD to those of controls
with mental retardation (MR) or developmental disabilities outside the autism spectrum.
Using results gathered in part one of the study, it was hypothesized that children with
autism or PDD would, on average, have lower birth weights than non-autistic controls
and would also be more likely to fall into LBW, VLBW, or ELBW categories.
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Statement of Purpose

Our primary objective in both parts of this study was to determine whether low birth
weight in general, and extremely low birth weight in particular, is linked to the
development of autism and pervasive developmental disorders later in childhood. Our
secondary objective was to investigate the role of adverse perinatal factors in the etiology
of autism spectrum disorders.

In the first part of the study, we hypothesized that a cohort of children bom at ELB W
(<1,000 grams) would demonstrate a higher prevalence of autistic behaviors and autism¬
like social and communication deficits than the average population.

In the second part of the study, we hypothesized that children with autism or PDD would
have lower mean birth weights than non-autistic controls, and would be more likely to
fall into low birth weight, very low birth weight, or extremely low birth weight
categories.
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Methods

I. ELBW and Development of Autistic Behaviors

Study Population
In part one of this study, we conducted a pilot study with a cohort of ELBW
children to determine whether a link between ELBW and the development of autistic
behaviors later in childhood might exist. Study participants were drawn from patients of
the Newborn Follow-Up (NBFU) Clinic at The Children’s Hospital of Alabama.
Children between the ages of 3 and 7, with birth weight less than 1,000 grams, were
eligible for the study. Only patients who lived within one hour of the clinic were
recruited, and children with significant neurologic impairments such as blindness,
profound deafness, and cerebral palsy were excluded due to the difficulty of performing
the ADOS reliably. Parents of children who met the criteria for the study were contacted
by phone (in the majority of cases) or at clinic visits. Given constraints of time and
resources, the decision was made not to include a control group in order to maximize the
number of ELBW subjects that could be tested, and to reduce investigator bias by having
a selection of videotaped ADOS sessions reviewed by a secondary scorer, unaware of the
context of the study.

Study Design
Approval was obtained from the Institutional Review Board at the University of
Alabama at Birmingham and from the Human Investigations Committee (HIC) at the
Yale University School of Medicine. Informed parental consent was obtained at the
beginning of each testing session. Three validated assessment tools, the Autism
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Diagnostic Observation Schedule, Vineland Adaptive Behavior Scales, and Autism
Behavior Checklist, in addition to the experimental Autism Screening Questionnaire,
were used to evaluate each child’s development, behavior, communicative abilities, and
social skills (see Appendix B for a brief overview of these assessments). Scores on the
Vineland, ABC, and ASQ were derived from parental responses, and ADOS scores were
obtained from observation of the child’s behavior during a set of language-appropriate
semi-structured activities. The ADOS module to be used was based on the child’s verbal
level as reported by the parent; module 1 was used for children without spontaneous
phrase speech, module 2 for those with flexible phrase speech but not fluency, and
module 3 for those with verbal fluency (at the level of a typical 4-year-old child). ADOS
sessions were videotaped with parental permission, and were scored by the test
administrator.1 As mentioned above, a small sample of these videotaped sessions was
scored independently by an ADOS-certified secondary scorer.
Demographic information, pregnancy and birth history, medical history, and
family history were obtained from the parent, as well as a list of medications taken by the
child. Discharge summaries and psychological tests from the subject’s chart were
reviewed to provide additional information about neonatal history and to obtain scores for
previously administered IQ tests.
Following the study, a report of the outcomes of the four assessments was
generated for each child, and distributed to parents and the NBFU clinic. Follow-up
treatment and repeated assessments through the NBFU and Sparks clinics were provided
for children with unusual or worrisome test results.
1 The ADOS administrator, the writer of this paper, underwent a one-week ADOS training session and
established reliability with an ADOS-certified colleague prior to administering the test for research
purposes.
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Outcomes
The results of the ADOS tests were used as the primary outcome measure, with
results of the Vineland, ABC, and ASQ contributing to the overall analysis. ADOS
results were compared to published data on the prevalence of autism spectrum disorders
in the general population; Vineland results were compared to established norms. Within
the ELBW group, performance on these tests was analyzed with reference to individual
birth weight and gestational age to determine if correlations existed between these factors
and the demonstration of autistic behaviors. Because of concerns that low IQ might
contribute to false positive results on the ADOS, we controlled for IQ (as measured by
the Bayley Scales of Infant Development, corrected for gestational age, and the
Differential Ability Scales [DAS]) in these correlations.

A variety of participant

charactenstics and perinatal factors (e.g., mental retardation, seizure disorder, retinopathy
of prematurity, intraventricular hemorrhage, bronchopulmonary dysplasia) were also
reviewed with reference to performance on the ADOS.

Statistical Analysis
Given the nature of the study, and the relatively small number of children eligible
for recruitment, we designed the protocol to include as many ELBW children as possible
during the active phase of the trial. In addition to recording the absolute number of
“positive” scores on the ADOS and its subsections, we estimated prevalence within a
95% confidence interval. Within the ELBW group, the Kendall rank correlation
coefficient was used to analyze correlations between continuous variables such as birth
weight and test scores, with a partial correlation coefficient used to control for the effects
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of IQ. Among the ADOS classification groups (autism range, ASD range, and normal
range), the Fisher exact probability test was used to compare categorical variables and the
Kruskall-Wallis test was used to compare birth weights. A conventional 2-sided p value
of less than 0.05 was retained throughout.

Role of Student
The medical student and writer of this thesis, under the supervision of Dr. Myriam
Peralta and Dr. Crayton Fargason (Department of Pediatrics, University of Alabama at
Birmingham) and Dr. Fred Volkmar (Child Study Center, Yale University School of
Medicine), helped to design the study and obtain Institutional Review Board approval.
The student and an assistant recruited all ELBW clinic patients for the study. The student
was trained in ADOS administration and administered and scored all ADOS tests, which
were videotaped for secondary review by Kirsten Bailey, a psychology fellow at the
University of Alabama at Birmingham. The student also obtained all demographic
information from the parents and patient charts and administered all ABC and ASQ
parent questionnaires. Approximately 2/3 of the Vineland tests were conducted by the
student, with the remaining 1/3 conducted by another person involved with the study. In
addition, under the direction of the advisors named above, the student performed the
statistical analysis for both portions of this study.

II.

Retrospective Analysis of Birth Weight in Autism and ASDs

Study Participants
In the second part of the study, cases and controls were drawn from patients seen
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in the Developmental Disabilities Clinic of the Child Study Center at Yale University
School of Medicine. All patients seen in the clinic for whom data on birth weight and IQ
were available were included in the study.

Study Design
After Yale HIC approval was obtained, a review of medical records of children
with and without autism spectrum disorders was performed. The purpose of this casecontrol study was to compare birth weights of children with autism and other ASDs to
those of non-autistic controls. Participants were divided into cases, which were then split
into two groups according to a diagnosis of autism or PDD, and controls. Autism or PDD
had been diagnosed by experts at the Developmental Disabilities Clinic.2 Control
subjects had been diagnosed with a variety of non-autistic disorders including attention
deficit disorder, bipolar disorder, blindness, cerebral palsy, conduct disorder, depression,
language disorder, learning disability, nonverbal learning disability, reactive attachment
disorder, social anxiety disorder, schizophrenia, Tourette’s syndrome, or simple mental
retardation. Due to diagnostic criteria that overlap with disorders within the autism
spectrum, patients with Childhood Disintegrative Disorder or Multiplex Developmental
Disorder were excluded to avoid confounding the data.

2

Interrater reliability of clinical diagnosis of autism and PDD based on DSM-IV criteria has been shown to
be excellent among experienced clinicians. In particular, the group of practitioners at the Yale Child Study
Center, who diagnosed the children in this study, participated in and published results from the DSM-IV
autism field trial. See Klin A, Lang J, Cicchetti DV, Volkmar FR. 2000. Brief report: interrater reliability
of clinical diagnosis and DSM-IV criteria for autistic disorder: results of the DSM-IV autism field trial. J
Aut Dev Disord. 30(2):163-7.
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Outcomes
The primary outcome measures were birth weight and gestational age. For
further analysis, cases and controls were divided according to presence or absence of
mental retardation, defined as full-scale intelligence quotient (FSIQ) < 70 on the
Kaufman Assessment Battery for Children (KABC), Leiter International Performance
Scale, Wechsler Intelligence Scale for Children (WISC), or Wechsler Adult Intelligence
Scale (WAIS). Secondary outcomes included a variety of factors contributing to
perinatal adversity, as reported by the child’s parent. These factors include general
concern about the baby’s condition, excessive maternal bleeding, meconium staining,
maternal fever and/or infection, forceps use, nuchal cord, placental abnormalities,
jaundice, use of incubator, feeding difficulties, or oxygen supplementation.

Statistical Analysis
The number of subjects in each group needed to demonstrate a statistically
significant difference among the groups was calculated beforehand, considering both
alpha and beta error. Using available birth statistics, we assumed a standard deviation in
birth weight of 500g. We predicted that 63 subjects per group would be needed to detect
a difference of 250g with a two-sided a value of 0.05. Continuous variables were
compared using one-way analysis of variance; the chi-square test was used for categorical
variables. Statistical significance was determined by two-sided p value of .05.
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Role of Student
In this portion of the study, the medical student obtained, organized, and analyzed
data from an existing database of patients seen in the Developmental Disabilities Clinic,
under the direction of Dr. Fred Volkmar.
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Results

I. Autism/ELBW trial
Of the 268 ELBW children who met criteria for the study, 27 were excluded for
cerebral palsy, 2 for blindness, and 3 for both cerebral palsy and blindness, leaving 236
eligible subjects. None of these children had hearing loss severe enough to merit
exclusion. Of the 236 eligible subjects, 122 were contacted, 42 were enrolled in the
study, 8 refused, and 72 did not return messages regarding the study. 114 children could
not be contacted due to wrong numbers or no answer. Reasons given for refusal included
distance from clinic (1), serious illness (1), time constraints (2), and lack of interest (4).
Of the 42 subjects initially enrolled in the study, 19 completed all tests required for the
study and were included in the analysis. (Figure 1)

Figure 1. ELBW Recruitment Analysis

268 area ELBW
children ages 3-7

32 excluded for CP
and/or blindness

236 eligible
children

114 not reached*

80 refused or did
not respond

122 contacted

42 enrolled

19 participated in
all tests

ELBW, extremely low birth weight; CP, cerebral palsy
* due to unavailability of current contact information or failure to answer telephone
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The baseline characteristics of the 19 children included in the analysis are detailed
in Table A. Many of the study participants, who were bom at weights ranging from 520
to 1000 grams, had been affected by various sequelae of prematurity, including
retinopathy of prematurity (ROP), intraventricular hemorrhage (IVH), bronchopulmonary
dysplasia (BPD), and cognitive deficits. Using IQ <70 on most recent test (Bayley
corrected mental age or DAS general conceptual ability) as the criterion for mental
retardation, four participants were determined to have MR.

■
Table A. ELBW Study Participant Characteristics
'
N
19
Mean age
5.33 years (SD 0.95, range 3.25-6.7)
Mean birth weight
853.47 grams (SD 142.38, range 520-1000)
Mean gestational age
26.74 weeks (SD 1.88, range 23-30)
Sex
9 female (47.4%)
...
10 male (52.6%)
Race
9 white (47.4%)
10 black (52.6%)
ROP
9 (47.4%)
Stage 1
5 (26.3%)
Stage 2
3(15.8%)
Stage 3
1(5.3%)
IVH
6(31.6%)
Grade 1
3 (15.8%)
Grade 2
2 (10.5%)
Grade 3
1 (5.3%)
BPD
4(21.1%)
IQ < 70*
4(21.1%)
;

■

••

•

’ .V

•; ■

-

’

.

ROP, retinopathy of prematurity; IVH, intraventricular hemorrhage; BPD, bronchopulmonary
dysplasia
* using latest result on Bayley Scales of Infant Development, corrected for gestational age, or the
Differential Ability Scales
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Out of 19 participants, 2 (10.5%) had an ADOS total score in ASD range and 1
other (5.3%) had a score in the autism range. Several children scored abnormally on one
or more of the ADOS subsets. For ADOS communication scores, 3 (15.8%) fell in ASD
range and 4 (21.1%) in autism range; for social scores, 2 (10.5%) fell in ASD range and 2
(10.5%) in autism range. (Figure 2)

Figure 2. ADOS Scores of ELBW Participants (n-19)
:
.

Classification of ADOS scores

Normal

Normal

r.y

Autism
range
ASD
range

Autism
range

ASD
range

Autism

_ _ __
'

Communication Score

Social Score

Total Score

ADOS category

ADOS, Autism Diagnostic Observation Schedule; ELBW, extremely low birth weight; ASD, autism
spectrum disorder

;
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Overall, 3 out of the 19 study participants, or 15.8% (standard error 16.4%; 95%
confidence interval, -0.6-32.2%), had ADOS total scores in the ASD (2) or autism (1)
range. All three were males between the ages of four and six at the time of testing; two
were white and one was black. Only one study participant scored within the ASD range
on both the ADOS and the parental questionnaires, the ASQ and ABC. No other
participants scored abnormally on the questionnaires. Test results for children with
abnormal ADOS scores are summarized in Table B.

,

it

;

Table B. Test Results for Chiildren with Abnormal ADOS S<;ores

* t
;

ADOS
social

ADOS
comm.

+

+
++
+

1
2
3
4
5
6
7
8
9

ADOS total

ABC

ASQ

+

++

+

+

'ViCi' v - ' ; ’'-r

++
+
+
++

++
++

++

++

ADOS, Autism Diagnostic Observation Schedule; ABC, Autism Behavior Checklist; ASQ, Autism
Screening Questionnaire
Participants with abnormal total ADOS scores (suggestive of autism or ASD) are highlighted.
+ within testing range for an ASD
++ within testing range for autism

ADOS sessions for 6 of the 19 participants, including 2 of the 3 with abnormal
total scores, were reviewed on videotape and rescored by an independent ADOS-certified
scorer, blinded to the initial results. The two children with abnormal initial scores were
again found to be within the autism or ASD range by this secondary reviewer. The

remaining four subjects were assigned secondary scores that were the same or slightly
higher than their initial ADOS scores.
Mean Vineland standard scores for ELBW children were more than one standard
deviation below the national norm in all categories (Table C), although within the ELBW
group there were no significant correlations between birth weight and standard or
composite scores (x =0.054, p=0.752 communication domain; x =0.251, p=0.140
socialization domain; x =0.222, p= 0.193 composite score). Domain scores were
uniformly low; mean socialization and communication scores were not significantly
different from daily living skills or from composite score (p = 0.363). The participant
with ASD-level scores on the ADOS, ABC, and ASQ had a relatively low socialization
raw score of 60 compared to scores of 74 in the communication and 88 in the daily living
skills domains. The other two participants with abnormal ADOS total scores did not
have socialization scores that were appreciably lower than those in the other domains
(their scores for the socialization, communication, and daily living skills domains were,
respectively, 70, 80, 67 and 57, 54, 32).

Table C,
■;

Compared to National Norms

■

ELBW
Communication
.
Daily Living Skills
Social
Composite_

_
NORM

83.42(13.125)

100(15.00)

82.84(13.129)
84.68 (14.708)
77.37 (13.238)

100(15.00)
100 (15.00)
100(15.00)

ELBW, extremely low birth weight.
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Because the scoring system and diagnostic cut-offs vary among the three ADOS
modules used in this study, we used the module with the most data points (module 3,
n=14) to assess correlation between ADOS scores and other factors; correlations not
including the ADOS used data from all participants (n=19). Within the ELBW group,
birth weight did not correlate significantly with scores on ADOS communication domain
(x =0.061, p=0.775), social (x =0.366, p=0.082) domain, or total (x =0.297, p=0.15).
There was no difference in birth weight among the three categorical ADOS
classifications (normal, ASD-range, or autism-range total score; p=0.32).
Likewise, there was no correlation found between birth weight and total scores on
the ABC (x = 0.047, p=0.779) or ASQ (x =0.248, p=0.156). However, gestational age
was found to correlate positively with ADOS social (x =0.650, p=0.004) and total scores
(x =0.525, p=0.019); that is, later gestational age was related to more abnormal scores.
IQ was controlled for in the analysis of ADOS, ABC, and ASQ scores.
Scores on the Bayley Scales of Infant Development, corrected for gestational age,
correlated positively with ADOS social scores (x =0.468, p=0.037), although no
association was seen between DAS General Conceptual Ability and ADOS results (x =
0.082-0.128, p=0.568-0.708).
When the perinatal and childhood histories of the participants who reached
abnormal cutoffs in the social (n=4) or communication (n=7) ADOS domains, or on the
ADOS total (n=3), were compared with the rest, there were no significant differences
observed in the occurrence of ROP, IVH, BPD, cardiac anomalies, seizure disorders,
developmental brain abnormalities, or mental retardation, or in the mode of delivery
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(p=0.17-1.00; see Table D). None of the study participants had a history of congenital
infection, traumatic brain injury or other postnatal injury, inborn error of metabolism,
maternal drug use, forceps use, or neonatal resuscitation.

~

Factor
ROP
IVH
BPD
Cardiac
Anomaly
Seizure
Disorder
Developmental
Brain
Abnormality
Mental
Retardation
Cesarean
Section

Communication Score
Normal
Abn
n=12
n=7
p value

Social Score
Normal
Abn
n=15
n=4
p value

Normal
n= 16

7
5
4
6

(58%)
(42%)
(33%)
(50%)

2 (29%)
1 (14%)
0
1 (14%)

0.350
0.333
0.245
0.173

8
5
4
6

(53%)
(33%)
(27%)
(40%)

1 (8%)

1 (14%)

1.000

2(13%)

1 (8%)

1 (14%)

1.000

2 (13%)

3 (25%)

1 (14%)

1.000

2 (13%)

1 (25%)
1 (25%)
0
1 (25%)

0.582
1.000
0.530
1.000

8
6
4
6

0

1.000

0

2 (50%)
i; , . . ’
2 (50%)

(50%)
(38%)
(25%)
(38%)

Total Score
Abn
n=3
p value
1 (33%)
0
0
1 (33%)

1.000
0.517
1.000
1.000

2(13%)

0

1.000

1.000

2(13%)

0

1.000

0.178

3 (19%)

1 (33%)

1.000

1.000

9 (56%)

2 (66%)

1.000

■,

,;/V

•'.A v

7 (58%)

4 (57%)

1.000

9 (60%)

ADOS, Autism Diagnostic Observation Schedule; ROP, retinopathy of prematurity; IVH, intraventricular
hemorrhage; BPD, bronchopulmonary dysplasia; Abn, abnormal,
p values determined by Fisher’s Exact Test (2-sided).

II. Case-control study
Out of 300 children for whom all necessary data were available, 4 were excluded
for diagnoses that did not fall squarely into either FDD or control groups: Childhood
Disintegrative Disorder (2) and Multiplex Developmental Disorder (2).

We included the

remaining 296 subjects in the analysis, including 74 patients with autism, 132 patients
with PDD, and 90 non-autistic controls.
As demonstrated in Table E, there were no significant differences among the
groups in age (mean 12.85-14.69 years, p=0.055) or gender distribution (p=0.944). The
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proportion of subjects with mental retardation (IQ<70) was 45% in the autism group,
compared to 12% in the PDD group and 21% in the control group (p<0.0005).

'
Table E. Baseline Patient Characteristics of Cases and Controls

N
Mean (SD)
age
Sex

. :
■ V.

!

Autism

PDD

Control

p value

74
14.69 (6.48) years

132
12.85 (4.35) years

90
13.6 (5.31) years

0.055

14F (19%)
60M (81%)

24F (18%)
108M (82%)

18F (20%)
72M (80%)

0.944
<0.0005*

IQ
<70
>70

33 (45%)
41 (55%)

16(12%)
116 (88%)

19(21%)
71 (79%)

PDD, pervasive developmental disorder.
* statistically significant (95% confidence interval)

Table F shows the results of the analysis. Mean birth weight (± SD) was 3458.4 ±
695.0 grams for the autism group, 3444.8 ± 483.4 grams for the PDD group, and 3364.3
± 664.6 grams for the control group (p=0.523). When birth weights for children with
IQ<70 were compared, there was a noticeable but nonsignificant trend toward higher
birth weight in the autism group (Figure 3; p=0.132); mean birth weight for those with
low IQ was 3514.6 ± 705.7 for the autism group, 3316.8 ± 449.7 for the PDD group, and
3138.5 ± 614.0 for the controls. Birth weights were similar across the three groups for
children with IQ > 70 (p=0.858), for female subjects (p=0.840), and for male subjects
(p=0.554).
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Table F. Birth Weight and Gestational Age in Cases and Controls
4"‘-

_

N
Mean (SD) birth
weight, in grams

Mean (SD)
gestational age,
■ in weeks.
Birth weight
category
NBW (>2500g)
LBW (<25Q0g)
VLBW (<1500g)
ELBW (<1000g)
Total <2500g

Autism

PDD

Control

74
3458.42 (695.0)

132
. ■ .
3444.82 (483.4)

90
3364.27 (664.61)

.

.

-

■ .

IQ<70 3514.55 (705.7)
IQ>70 3413.25 (691.7)

IQ<70 3316.76(449.7)
IQ>70 3462.48 (487.0)

F 3425.32 (521.6)
M 3466.15 (733.1)
■y .
■

F 3341.6(456.8)
M 3467.75 (488.14)

39.42 (2.04)
:: . : ■ ■

70 (94.6%)
2 (2.7%)
2 (2.7%)
0
4 (5.4%)

39.37(1.90)

.

p value

mm
0.523

IQ<70 3138.46 (614.0)
IQ>70 3424.70 (653.0)

F 3336.49(451.6)
M 3371.21 (710.4)
lplI7(VL77®Iplil . .
39.20 (2.69)

0.132
0.858
0.840
0.554
0.825

.

127 (96.2%)
5 (3.8%)
0
0
5 (3.8%)

84 (93.3%)
5 (5.6%)
0
1 (1.1%)
6 (6.7%)

0.623

NBW, normal birth weight; LBW, low birth weight; VLBW, very low birth weight; ELBW, extremely low
birth weight; PDD, pervasive developmental disorder.

Mean gestational age was 39.4 ± 2.0 weeks for the autism group, 39.4 ±1.9
weeks for the PDD group, and 39.2 ± 2.7 weeks for the controls (p=0.825). Only 4
(5.4%) of the autism group, 5 (3.8%) of the PDD group, and 6 (6.7%) of the control
group fell into one of the low birth weight categories (LBW, VLBW, or ELBW); there
was no significant difference in the percentage of children with birth weight < 2500
grams among cases and controls (p=0.623).
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□

Control

When adverse perinatal events and conditions (parentally reported) were
analyzed, there were no differences observed among groups in overall concern about the
baby’s condition during labor (p=0.992), excessive bleeding before (p=0.365) or during
(p=0.563) labor, meconium staining (p=0.066), maternal fever and/or infection
(p=0.543), forceps use (p=0.652), nuchal cord (p=0.201), or placental abnormalities
(previa or abruptio; p=0.789). Likewise, there were no differences in treated (p=0.322)
or untreated (p=0.929) jaundice, use of incubator (p=0.251), feeding difficulties
(p=0.635), or oxygen supplementation (p=0.661). See Table G for a summary of these
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results. There were also no differences in the proportion of cases in each group with 0-1,
2-3, or >3 adverse conditions (p=0.849). The number of data points varies with each of
these factors (n = 190-289), as full perinatal data was not available for all subjects.

HP.■

.SBBS

*

Hi .

JH .^JPHHIHI

Table G. Summary of Parentally Reported Adverse Perinatal Factors in Cases and Controls
i'tm. MBS
■>7 -v
_
Factor
Concern over fetal condition in
labor
Excessive bleeding before
delivery
Meconium

Total
n

Autism
group

246
„A
288
249

■

Adverse factor reported
PDD group
Control
group

P
value

15/59 (25.4%)

28/110(25.5%)

19/77 (24.7%)

0.992

3/73 (4.1%)

2/127 (1.6%)

1/88 (1.1%)

0.365

4/79 (5.1%)

0.066

4/62 (6.5%)

0.543

3/59(5.1%)

15/111 (13.5%)
■■ ‘
.
. f.
9/82(11.0%)

Maternal fever/infection

190

3/46 (6.5%)

Excessive bleeding during
delivery
Forceps use

249

1/59(1.7%)

5/111 (4.5%)

2/79 (2.5%)
■

0.563

251

5/59 (8.5%)

11/111 (9.9%)

5/81 (6.2%)

0.652

Nuchal cord

289

5/73 (6.8%)

14/127 (11.0%)

4/89 (4.5%)

0.201

Placenta previa or abruptio

285

3/72 (4.2%)

3/124 (2.4%)

3/89 (3.4%)

0.789

Untreated transient jaundice

280

10/67 (14.9%)

21/125 (16.8%)

15/88(17.0%)

0.929

Jaundice requiring phototherapy

250

13/58 (22.4%)

15/112(13.4%)

14/80(17.5%)

0.322

Incubator use

287

6/70 (8.6%)

12/128 (9.4%)

14/89(15.7%)

0.251

Feeding difficulties

246

7/56(12.5%)

20/111 (18.0%)

14/79(17.7%)

0.635

Oxygen supplementation

285

5/70 (7.1%)

13/127 (10.2%)

10/88(11.4%)

0.661

PDD, pervasive developmental disorder.

28

Discussion

Taken together, our pilot study exploring the possible connection between
extremely low birth weight and the later development of autistic behaviors, and our casecontrol analysis of birth weight and gestational age in autistic, PDD, and control
populations, raise several interesting points about the nature and etiology of autism. The
first study suggests that ELBW children may be at risk for developing autism-like deficits
in communication and reciprocal social interaction. The second leads us to conclude that
low birth weight is not a major risk factor for autism and PDD in a larger group of
children.
In our study of 19 ELBW children, a higher-than-expected number scored in the
autism and ASD ranges on the ADOS tests, suggesting that these children may be at
higher risk than children of normal birth weight for developing deficits in communication
and social interaction suggestive of an ASD. It should be emphasized that scoring
abnormally on a subset of the ADOS does not, in itself, indicate a diagnosis of ASD;
rather, it is the total score that counts.

Indeed, the fact that only one child scored in the

ASD range on all administered tests (and therefore likely falls into the diagnostic
category of PDD-NOS) indicates that most of the children did not meet the criteria for an
ASD despite their abnormal performance on the ADOS. Overall, 3/19 (15.8%) children
had an ASD- or autism-level total score on the ADOS, and 1/19 (5.3%) had ASD-level
scores on all tests; by comparison, estimated prevalence for ASDs in the general
population is approximately 60/10,000 (0.6%).
Although ELBW children scored abnormally on the ADOS with surprising
frequency, we saw no correlation within the group between birth weight and ADOS
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scores, nor between birth weight and ABC, ASQ, or Vineland scores. This lack of
correlation may be due to the small sample size or to the possibility that while being bom
at ELBW increases risk, there are no significant differences in risk within the small 500
gram weight range. We did, however, see a positive correlation between gestational age
and ADOS social scores. This correlation leads us to wonder whether some sort of
growth restriction, resulting in children who have relatively late gestational ages but low
birth weights, might play into later impairments in social interaction, although with such
a small sample size this finding is difficult to generalize. Higher IQ measured earlier in
life (as demonstrated by the Bayley Scales of Infant Development) correlated with higher
ADOS social scores, but there was no association between social scores and IQ measured
later in life (measured by the DAS). These findings help to dismiss notions that low IQ
might contribute to false positive results on the ADOS. Overall, correlations using
ADOS scores are necessarily imperfect and should be interpreted with caution because
the ADOS uses cutoff scores for diagnosis of PDD or of autism. According to the ADOS
design, whether a score falls above or below a given cutoff (which is a different number
for each of the modules) is more significant than the absolute score. To correct partially
for this, we used only module 3 data (the module given to the majority of the
participants) for correlations.
Mean Vineland standard scores for the ELBW children were more than one
standard deviation below the norm in all domains, a finding that was not particularly
surprising given the significant developmental delays and limitations in cognitive and
executive function often seen with in this group of children. Patterns of Vineland domain
scores for developmentally disordered children have been previously described, and can
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be useful in discriminating autism from other disorders. One group (78) has shown that
autistic children tend to have low socialization scores for chronological and mental age (a
ratio of actual to age-predicted socialization scores 3.5 standard deviations below the
normative sample is most indicative of autism). This method, however, did not prove
useful in distinguishing PDD from other diagnoses. Other studies (79-81) have identified
patterns of low socialization performance, intermediate communication skills, and
relatively high function in terms of daily living skills for the autistic population. We did
not observe such patterns in the ELBW group as a whole (in which performance in all
adaptive behavior domains was uniformly low), but did note a pattern suggestive of
autism in the raw domain scores of the one participant who scored in the ASD domain on
all administered tests. This finding increases our suspicion that this individual’s
diagnosis of an ASD was correct.
This pilot study has several limitations. Unfortunately, despite efforts to recruit
enough subjects for statistical significance, only 19 subjects could be fully tested, thus
limiting the power of the study. Therefore, our data are insufficient to estimate the
prevalence of ASDs in the ELBW population as a whole. We cannot exclude the
possibility that our results occurred by chance alone, or as a result of patient self¬
selection (i.e., the possibility that parents with “problem” children were more eager to
participate in the study). However, our results - strengthened by the corroboration of a
blinded secondary ADOS scorer - do point to a potential connection between ELBW and
autistic behaviors that should be further investigated on a larger scale.
Another potential weakness centers around the lack of controls and the resulting
potential for investigator bias. Early in the design of this pilot study, the decision was
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made not to include a control group of normal birth weight children in order to maximize
testing of ELBW children in the limited time available. Because standardized norms
exist for each of the assessment tools used, the ELBW children in the study were
compared against these norms rather than against a control group. Concerns about
investigator bias in the ADOS test were addressed by having a second person, unaware of
the context of the study, rescore a random sample of ADOS tests. The other three
instruments used - the Vineland, ABC, and ASQ - were based either exclusively or
primarily on parental response and were thus less subject to investigator bias.
Conversely, the exclusion of children with cerebral palsy (due to the difficulty of
administering the ADOS to such children) may have contributed to a falsely low number
of abnormal scores. Cerebral palsy is associated with neurobehavioral disorders,
including autism, in up to 50% of cases (82). Although there were no children with
hearing loss severe enough to merit exclusion on our particular study, it should also be
noted for future investigations that an association between autism and deafness has been
shown to exist. One group (83) found moderate-severe to profound hearing loss in 1015% of autistic cases.
The ADOS is designed to catch abnormalities in communication and social
interaction that are relatively specific to disorders in the autism spectrum. Our findings
suggest that the subtle deficits picked up during ADOS testing in several of the ELBW
children are similar in character to those seen in autism and autism spectrum disorders,
even though these children would not be diagnosed as having an ASD. Furthermore,
given that outcomes in autistic children can be markedly improved by early intervention,
it is possible that timely recognition and management of these subtle problems with
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communication and sociability may be beneficial to those ELBW children who are
affected.
Thus, although our data cannot be used reliably to estimate the prevalence of ASD
in the ELBW population, we offer clinically interesting results that we hope will inform
the design of larger, controlled studies. The sample size needed for a definitive study
comparing ASDs in ELBW and control populations would require between 200 and
several thousand subjects per group, depending on initial assumptions, and would likely
necessitate a coordinated effort by several institutions caring for ELBW children.
For the second part of this work - the case-control study - we calculated sample
size ahead of time to avoid the difficulties with low statistical power encountered in the
first part. Our case and control groups were similar in mean age and gender distribution.
As expected, the autistic group had a higher incidence of mental retardation than the
other two groups. We observed no significant differences in birth weight or gestational
age among the autism, PDD, and control groups as a whole or when the groups were
stratified according to IQ or gender. In the active debate over birth-related etiologies of
autism, this finding supports those studies that suggest that birth weight is not a
significant risk factor for autism. Likewise, we found no relationship between adverse
perinatal factors (nonreassuring fetal status during labor, excessive maternal bleeding,
meconium staining, maternal fever or infection, forceps use, nuchal cord, placental
abnormalities, hyperbilirubinemia, incubator use, feeding difficulties, or oxygen
supplementation) and the development of autism or PDD.
Interestingly, within the subgroup of participants with mental retardation, autistic
subjects had higher birth weights than PDD subjects, who in turn had higher birth
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weights than controls, although this trend was not significant within the 95% confidence
interval. Low birth weight has been classically associated with cognitive deficits secondary to neurologic damage (from trauma, asphyxia, or spontaneous intracerebral
hemorrhage) related to the underdeveloped brain and body of the premature infant - but
the autistic children with MR had even higher birth weights than the autistic group as a
whole. This implies that cognitive deficits in autistic children may stem from a
secondary process unrelated to birth parameters, perhaps the same neurologic process that
has caused the autism itself. Such an idea fits nicely with the abnormal brain growth
hypothesis of autism, referenced earlier in this paper (17), in suggesting that something
happens to the brain after birth (be it formation of abnormal neural connections, glial
proliferation, or some other as yet undefined process) to cause autism and also, in many
cases, concurrent mental retardation.
In conclusion, the findings of these two related studies produce an interesting
picture about the nature and root causes of autism. Many experts now believe that
disorders within the autism spectrum are likely the end result of a variety of factors,
genetic and/or environmental, rather than the consequence of a single defined set of
events or insults. That is, the cause of autism is almost certainly not the same for all
affected individuals. Thus, while our data demonstrate that low birth weight is unlikely to
be a major risk factor for ASDs, it is possible that the small subgroup bom at ELBW (and
thus at special risk for neurologic sequelae) may have a tendency to develop autism-like
behavioral derangements even if low-birth-weight children in general do not. Given the
striking prevalence of subtle deficits in social and communication skills seen in the
ELBW children in this study, as well as the potential for correcting these deficits with

early intervention, we eagerly await the generation of additional data to determine
whether screening ELBW children for autism-like deficits is warranted.
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APPENDIX A
DSM-IV CRITERIA FOR AUTISTIC DISORDER (299.0)
I.

A total of at least six items from (A), (B), and (C), with at least two from (A), and one each
from (B) and (C)
A. Qualitative impairment in social interaction, as manifested by at least two of the
following:
1. marked impairments in the use of multiple nonverbal behaviors such as eyeto-eye gaze, facial expression, body posture, and gestures to regulate social
interaction
2. failure to develop peer relationships appropriate to developmental level
3. markedly impaired expression of pleasure in other people’s happiness
4. lack of social or emotional reciprocity
B. Qualitative impairments in communication as manifested by at least one of the following:
1. delay in, or total lack of, the development of spoken language (not
accompanied by an attempt to compensate through alternative modes of
communication such as gesture or mime)
2. in individuals with adequate speech, marked impairment in the ability to
initiate or sustain a conversation with others
3. stereotyped and repetitive use of language or idiosyncratic language
4. lack of varied, spontaneous make-believe play or social imitative play
appropriate to developmental level
C. Restricted repetitive and stereotyped patterns of behavior, interests and activities, as
manifested by at least one of the following:
1. encompassing preoccupation with one or more stereotyped and restricted
patterns of interest that is abnormal either in intensity or focus
2. apparently inflexible adherence to specific, nonfunctional routines or rituals
3. stereotyped and repetitive motor mannerisms (e.g hand or finger flapping or
twisting, or complex whole-body movements)
4. persistent preoccupation with parts of objects

II.

Delays or abnormal functioning in at least one of the following areas, with onset prior to age 3
years:
A. Social interaction
B. Language as used in social communication
C. Symbolic or imaginative play

III.

The disturbance is not better accounted for by Rett's Disorder or Childhood Disintegrative
Disorder

From the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. 1994. Washington, DC:
American Psychiatric Association. 886 pp.

APPENDIX B
I.

The Autism Diagnostic Observation Schedule - Generic

“The Autism Diagnostic Observation Schedule - Generic (ADOS-G), is a semi-structured
assessment of social interaction, communication, play and imaginative use of materials for individuals
who may have autism or other pervasive developmental disorders (PDD). As port of the schedule,
planned social occasions, referred to as “presses”, are created which a range of social initiations and
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resonses is likely to appear. In the same way, communication opportunities are designed to elicit a
range of interchanges. Play situations are included to allow observation of a range of imaginative
activities and social role-play. The goal of the ADOS-G is to provide presses that elicit spontaneous
behaviors in standardized contexts. Structured activities and materials, and less structured interactions,
provide standard contexts within the ADOS-G in which social, communicative and other behaviors
relevant to the understanding of pervasive developmental disorders are observed....
“The modules provide social-communicative sequences that combine a series of unstructured
and structured situations. Each situation provides a hierarchy of presses for particular social behaviors.
Module 1... is intended for children who do not use spontaneous phrase speech consistently. It
consists of 10 activities with 29 accompanying ratings. Module 2 is intended for children with some
flexible phrase speech who are no verbally fluent. It consists of 14 activities with 28 accompanying
ratings. Module 3 provides 13 activities and 29 ratings. It is based on the ADOS and is intended for
verbally fluent children for whom playing with toys is age-appropriate. The operational definition of
verbal fluency is the spontaneous, flexible use of sentences, with multiple clauses that describe logical
connections within a sentence. It requires the ability to talk about objects or events not immediately
present. Module 4 contains the socioemotional questions of the ADOS, along with interview items
about daily living and additional tasks. It is intended for verbally fluent adults and for adolescents
whoa re not interested in playing with toys such as actions figures (usually over 12-16 years). This
module consists of 12-15 activities with 30 accompanying ratings.”

Cutoff scores for ADOS domains:
Module 1
Communication: autism cut-off = 4, autism spectrum cut-off -2
Reciprocal Social Interaction: autism cut-off = 7, autism spectrum cut-off -4
Communication + Social (Total): autism cut-off = 12, autism spectrum cut-off =7
Module 2
Communication: autism cut-off = 5, autism spectrum cut-off =3
Reciprocal Social Interaction: autism cut-off = 6, autism spectrum cut-off =4
Communication + Social (Total): autism cut-off = 12, autism spectrum cut-off =8
Module 3
Communication: autism cut-off = 3, autism spectrum cut-off -2
Reciprocal Social Interaction: autism cut-off = 6, autism spectrum cut-off =4
Communication + Social (Total): autism cut-off = 10, autism spectrum cut-off =7
From Lord C, Risi S, Lambrecht L, Cook EH, Leventhal BL, et al. 2000. The Autism Diagnostic
Observation Schedule-Generic: a standard measure of social and communication deficits associated
with the spectrum of autism. JAut Dev Disord. 30(3):205-223.

II.

Autism Behavior Checklist

“The Autism Behavior Checklist (ABC) is a checklist of nonadaptive behaviors, capable of
providing a general picture of how an individual ‘looks’ in comparison with others. The profile of an
individual’s behavior is accomplished by quantifying the behavioral characteristics on the checklist.”
Either the teacher or the parent completes the checklist, which asks questions about behaviors
in five domains: sensory, relating, body and object use, language, and social and self-help. The total
score, derived from the sum of scores in these five areas, is predictive of a diagnosis of autism. “An
ABC score of 68 or higher has been selected as a high-probability cutoff point for the classification of
autism. Scores between 54-67 fall within one standard deviation of the autistic samples studied. ABC
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scores between 54-67 are considered to be in the moderate-probability range for the classification of
autism. Scores between 47-53 may cause administrators confusion... Diagnosis and educational
planning for these borderline individuals are greatly facilitated by administering [other tests].”
From Krug DA, Arick JR, Almond PA. 1993. Autism Screening Instrument for Educational Planning,
Second Edition: Examiner’s Manual. Austin, TX: ProEd.

III.

Autism Screening Questionnaire

The Autism Screening Questionnaire (ASQ) “consists of 40 questions that are based on the
ADI-R [Autism Diagnostic I nterview-Revised] but which have been modified into a form
understandable by parents without further explanation. These are questions on reciprocal social
interaction (such as social smiling, interest in other children, and offering comfort to others), language
and communication (including the use of conventional gestures, reciprocal conversation, and
stereotyped utterances), and repetitive and stereotyped patterns of behaviours (including circumscribed
interests and unusual preoccupations). In addition, the ASQ includes a question about self-injurious
behaviour and a question about the individual’s current language functioning.”
“Scores of 15 or more [are suggested] as the standard optimal cut-off for differentiating PDDs
(including autism) from other diagnoses. The sensitivity was 0.85, specificity 0.75, positive predictive
value 0.93, and negative predictive value 0.55 [in the sample tested].... A much higher cut-off (22 or
more) [are] required to separate autism from PDDs, the sensitivity being 0.75 and specificity 0.60 at
that point.”
From Berument SK, Rutter M, Lord C, Pickles A, Bailey A. 1999. Autism screening questionnaire:
diagnostic validity. Br J Psychiatry. 175:444-451.

IV.

Vineland Adaptive Behavior Scales

‘The Vineland Adaptive Behavior Scales... assess personal and social sufficiency of
individuals from birth to adulthood. The scales are applicable to handicapped and nonhandicapped
individuals. Like the original, the revised Vineland does not require the direct administration of tasks
to an individual, but instead requires a respondent who is familiar with the individual’s behavior....
[The revised Vineland] measures adaptive behavior in four domains: Communication, Daily Living
Skills, Socialization, and Motor Skills. In addition, [it includes] a Maladaptive Behavior domain, the
administration of which is optional.
“The Survey Form, containing 297 items, provides a general assessment of adaptive behavior,
which is useful for determining areas of strength and weakness. A trained interviewer administers the
Survey Form to a parent of caregive of an individual from birth to 18 years 11 months or a lowfunctioning adult. The semi-structured interview typically lasts between 20 and 60 minutes. The user
of the Survey Form obtains norm-referenced information based on the performance of representative
national standardization samples of about 4,800 handicapped and nonhandicapped individuals.”
Raw scores obtained in the domains of the Vineland are then converted into standard scores
according to chronological age. “Standard scores express in standard deviation units the extent to
which the individual’s score exceeds or falls below the mean score of persons the same age with whom
the instrument was standardized.... Vineland standard scores have a mean of 100 and a standard
deviation of 15.”
From Sparrow SS, Balia DA, Cicchetti DV. 1984. Vineland Adaptive Behavior Scales: Interview
Edition, Survey Form Manual. Circle Pines, MN: American Guidance Service.
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